Secondary Logo

Journal Logo

September 2007 - Volume 30 - Issue 6
pp: 577-674



High Mobility Group Box I (HMGB1) Release From Tumor Cells After Treatment: Implications for Development of Targeted Chemoimmunotherapy

Dong, Xiang Da (Eric); Ito, Norimasa; Lotze, Michael T.; More

Journal of Immunotherapy. 30(6):596-606, September 2007.


Phase 1/2 Clinical Trial of Interferon α2b and Weekly Liposome-encapsulated All-trans Retinoic Acid in Patients With Advanced Renal Cell Carcinoma

Boorjian, Stephen A.; Milowsky, Matthew I.; Kaplan, Jodi; More

Journal of Immunotherapy. 30(6):655-662, September 2007.

Effective Clinical-scale Production of Dendritic Cell Vaccines by Monocyte Elutriation Directly in Medium, Subsequent Culture in Bags and Final Antigen Loading Using Peptides or RNA Transfection

Erdmann, Michael; Dörrie, Jan; Schaft, Niels; More

Journal of Immunotherapy. 30(6):663-674, September 2007.